Blackstone Inc’s CalciMedica CALC Stock Holding History

Blackstone Inc’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-137,885	Closed	-$56M	–	498
2020 Q4	$56M	Hold	137,885	–	–	0.2%	48
2020 Q3	$24.5M	Buy	+137,885	New	+$28.7M	0.1%	59

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AlpInvest Partners Amsterdam, Netherlands $49.7M AUM 23.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blackstone Inc's CALC Position: Q1 2021 in Review

Blackstone Inc sold out of CalciMedica (CALC) in Q1 2021, closing a stake of 137,885 shares — an estimated $56M sold.

Blackstone Inc first reported a position in CALC in Q3 2020 and held it in 2 quarters. The position peaked at $56M in Q4 2020. 51 funds tracked by Wall St. Rank hold CALC as of Q1 2021.

Blackstone Inc reported no remaining CalciMedica position as of Q1 2021 after selling out during the quarter.
Blackstone Inc sold 137,885 CalciMedica shares in Q1 2021, an estimated $56M.
Blackstone Inc first reported a position in CalciMedica in Q3 2020 and held it in 2 quarters.
Blackstone Inc's CalciMedica position peaked at $56M in Q4 2020.
51 funds tracked by Wall St. Rank held CalciMedica as of Q1 2021.

Based on Blackstone Inc's 13F filing for Q1 2021, filed 17 May 2021.